Secondary malignancy after radiotherapy for Hodgkin Lymphoma
Hodgkin lymphoma (HL), formerly called Hodgkin disease, has attained high survival rates (≥75% at ten years for all grades and stages combined, age-standardised), with continued improvements in treatment modalities since the 1940s, when radiotherapy was first used to combat the disease. Today, sequential chemotherapy and radiation are used in many cases, but certain groups of […]
Dr H M Shaw, Dr W Topping
Mount Vernon Cancer Centre, Lister Hospital